CY1107627T1 - Βελτιωμενα εμβολια dna για τον ιο του βοειου απλου ερπητα-1 - Google Patents
Βελτιωμενα εμβολια dna για τον ιο του βοειου απλου ερπητα-1Info
- Publication number
- CY1107627T1 CY1107627T1 CY20071100201T CY071100201T CY1107627T1 CY 1107627 T1 CY1107627 T1 CY 1107627T1 CY 20071100201 T CY20071100201 T CY 20071100201T CY 071100201 T CY071100201 T CY 071100201T CY 1107627 T1 CY1107627 T1 CY 1107627T1
- Authority
- CY
- Cyprus
- Prior art keywords
- herpes virus
- dna vaccines
- aliphatic radical
- bovine herpes
- enhanced dna
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Εμβόλιο DNA κατά ενός παθογόνου που προσβάλλει τα προσοδοφόρα ζώα, ειδικά τα βοοειδή ή τους χοίρους, περιλαμβάνον ένα πλασμίδιο περιέχον μία αλληλουχία νουκλεοτιδίων η οποία κωδικοποιεί ένα ανοσογόνο ενός παθογόνου του θεωρούμενου ζωικού είδους, υπό συνθήκες επιτρέπουσες την έκφραση in vivo αυτής της αλληλουχίας, και ένα κατιονικό λιπίδιο περιέχον ένα άλας τεταρτοταγούς αμμωνίου, τύπου (I) στον οποίο το R1 είναι μία γραμμική, κορεσμένη ή ακόρεστη, αλειφατική ρίζα, έχουσα 12 έως 18 άτομα άνθρακα, το R2 είναι μία άλλη αλειφατική ρίζα, περιέχουσα 2 ή 3 άτομα άνθρακα, και το Χ μία ομάδα υδροξυλίου ή αμίνης, όπου αυτό το λιπίδιο είναι κατά προτίμηση το DMRIE.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0000798A FR2804028B1 (fr) | 2000-01-21 | 2000-01-21 | Vaccins adn ameliores pour animaux de rente |
| EP01907651A EP1248650B1 (fr) | 2000-01-21 | 2001-01-19 | Vaccins adn ameliores pour herpesvirus-1 bovin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107627T1 true CY1107627T1 (el) | 2013-04-18 |
Family
ID=8846183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100201T CY1107627T1 (el) | 2000-01-21 | 2007-02-14 | Βελτιωμενα εμβολια dna για τον ιο του βοειου απλου ερπητα-1 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1248650B1 (el) |
| JP (1) | JP2004500375A (el) |
| KR (1) | KR100820893B1 (el) |
| CN (2) | CN1404398B (el) |
| AR (1) | AR027926A1 (el) |
| AT (1) | ATE346611T1 (el) |
| AU (1) | AU783865B2 (el) |
| BR (2) | BR0107767A (el) |
| CA (1) | CA2398229C (el) |
| CY (1) | CY1107627T1 (el) |
| DE (1) | DE60124862T2 (el) |
| DK (1) | DK1248650T3 (el) |
| ES (1) | ES2277913T3 (el) |
| FR (1) | FR2804028B1 (el) |
| HU (1) | HU229597B1 (el) |
| MX (1) | MXPA02007110A (el) |
| NZ (1) | NZ520270A (el) |
| PL (1) | PL209304B1 (el) |
| PT (1) | PT1248650E (el) |
| WO (1) | WO2001052888A2 (el) |
| ZA (1) | ZA200205698B (el) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| US7078388B2 (en) | 2000-01-21 | 2006-07-18 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| CA2756797C (en) * | 2002-12-23 | 2015-05-05 | Vical Incorporated | Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| EP1594537B1 (en) * | 2003-02-19 | 2012-10-24 | Merial | Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3 |
| US20050214316A1 (en) | 2003-11-13 | 2005-09-29 | Brown Thomas P | Methods of characterizing infectious bursal disease virus |
| CU23544A1 (es) | 2006-02-28 | 2010-06-17 | Ct Ingenieria Genetica Biotech | Antígenos vacunales quiméricos contra el virus de la peste porcina clásica |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| EP3590533A1 (en) * | 2009-05-22 | 2020-01-08 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| CN103547286B (zh) * | 2010-11-19 | 2016-10-19 | 北京凯因科技股份有限公司 | 一种用于预防和治疗乙型肝炎的dna疫苗组合物 |
| CN112034169A (zh) * | 2020-08-27 | 2020-12-04 | 华威特（江苏）生物制药有限公司 | 用于检测牛病毒性腹泻病毒1型的直接免疫荧光试剂及其试剂盒 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9304089A (es) * | 1992-07-08 | 1994-01-31 | Schering Corp | Uso de gm-csf como una vacuna adyuvante. |
| EP1624068A1 (en) * | 1993-06-01 | 2006-02-08 | Life Technologies Inc. | Genetic immunization with cationic lipids |
| US5658785A (en) * | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| WO1996007739A2 (en) * | 1994-09-09 | 1996-03-14 | Neurocrine Biosciences, Incorporated | Interleukin-1 type 3 receptors |
| US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
| US5719131A (en) * | 1994-12-09 | 1998-02-17 | Genzyme Corporation | Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
| CA2214029A1 (en) * | 1995-04-25 | 1996-10-31 | Magda Marquet | Single-vial formulations of dna/lipid complexes |
| JPH11508231A (ja) * | 1995-05-26 | 1999-07-21 | ソマティックス セラピー コーポレイション | 安定な脂質／核酸複合体を含む送達ビヒクル |
| FR2751228B1 (fr) * | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
| FR2751229B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
| FR2751224B1 (fr) * | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
| AU1987197A (en) * | 1997-03-10 | 1998-09-29 | Heather Lynn Davis | Gene delivery to mucosal epithelium for immunization or therapeutic purpose |
| AUPO856097A0 (en) * | 1997-08-14 | 1997-09-04 | Commonwealth Scientific And Industrial Research Organisation | Vector |
| BR0011732B1 (pt) * | 1999-06-10 | 2014-02-04 | Vacinas de dna para animais de companhia e de esporte | |
| US6943152B1 (en) * | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
-
2000
- 2000-01-21 FR FR0000798A patent/FR2804028B1/fr not_active Expired - Lifetime
-
2001
- 2001-01-19 MX MXPA02007110A patent/MXPA02007110A/es active IP Right Grant
- 2001-01-19 JP JP2001552935A patent/JP2004500375A/ja active Pending
- 2001-01-19 PT PT01907651T patent/PT1248650E/pt unknown
- 2001-01-19 DK DK01907651T patent/DK1248650T3/da active
- 2001-01-19 CA CA2398229A patent/CA2398229C/en not_active Expired - Lifetime
- 2001-01-19 NZ NZ520270A patent/NZ520270A/en not_active IP Right Cessation
- 2001-01-19 PL PL356554A patent/PL209304B1/pl unknown
- 2001-01-19 AT AT01907651T patent/ATE346611T1/de active
- 2001-01-19 CN CN018054072A patent/CN1404398B/zh not_active Expired - Lifetime
- 2001-01-19 AU AU35566/01A patent/AU783865B2/en not_active Expired
- 2001-01-19 CN CNA2008101667835A patent/CN101554480A/zh active Pending
- 2001-01-19 KR KR1020027009300A patent/KR100820893B1/ko active IP Right Grant
- 2001-01-19 ES ES01907651T patent/ES2277913T3/es not_active Expired - Lifetime
- 2001-01-19 BR BR0107767-8A patent/BR0107767A/pt not_active IP Right Cessation
- 2001-01-19 DE DE60124862T patent/DE60124862T2/de not_active Expired - Lifetime
- 2001-01-19 BR BRPI0107767-8A patent/BRPI0107767B1/pt unknown
- 2001-01-19 WO PCT/FR2001/000187 patent/WO2001052888A2/fr active IP Right Grant
- 2001-01-19 HU HU0203974A patent/HU229597B1/hu unknown
- 2001-01-19 EP EP01907651A patent/EP1248650B1/fr not_active Expired - Lifetime
- 2001-01-22 AR ARP010100267A patent/AR027926A1/es not_active Application Discontinuation
-
2002
- 2002-07-17 ZA ZA200205698A patent/ZA200205698B/en unknown
-
2007
- 2007-02-14 CY CY20071100201T patent/CY1107627T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101554480A (zh) | 2009-10-14 |
| DK1248650T3 (da) | 2007-04-16 |
| EP1248650A2 (fr) | 2002-10-16 |
| CA2398229C (en) | 2012-05-15 |
| BRPI0107767B1 (pt) | 2017-10-24 |
| HUP0203974A3 (en) | 2004-07-28 |
| AU3556601A (en) | 2001-07-31 |
| PT1248650E (pt) | 2007-02-28 |
| BR0107767A (pt) | 2002-11-12 |
| AR027926A1 (es) | 2003-04-16 |
| EP1248650B1 (fr) | 2006-11-29 |
| NZ520270A (en) | 2004-08-27 |
| WO2001052888A3 (fr) | 2001-12-20 |
| HUP0203974A2 (hu) | 2003-03-28 |
| CN1404398A (zh) | 2003-03-19 |
| ES2277913T3 (es) | 2007-08-01 |
| FR2804028A1 (fr) | 2001-07-27 |
| CN1404398B (zh) | 2012-05-02 |
| CA2398229A1 (en) | 2001-07-26 |
| KR100820893B1 (ko) | 2008-04-10 |
| DE60124862D1 (de) | 2007-01-11 |
| FR2804028B1 (fr) | 2004-06-04 |
| PL209304B1 (pl) | 2011-08-31 |
| DE60124862T2 (de) | 2007-07-05 |
| ATE346611T1 (de) | 2006-12-15 |
| AU783865B2 (en) | 2005-12-15 |
| PL356554A1 (en) | 2004-06-28 |
| KR20020084093A (ko) | 2002-11-04 |
| HU229597B1 (en) | 2014-02-28 |
| MXPA02007110A (es) | 2003-01-28 |
| JP2004500375A (ja) | 2004-01-08 |
| ZA200205698B (en) | 2003-09-29 |
| WO2001052888A2 (fr) | 2001-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107627T1 (el) | Βελτιωμενα εμβολια dna για τον ιο του βοειου απλου ερπητα-1 | |
| NZ757210A (en) | Oil-based adjuvants | |
| ATE461709T1 (de) | Choline-bindende proteine derivate aus pneumokoken als impfstoff | |
| CY1107812T1 (el) | Καλλιεργητικο μεσον με εκχυλισμα σογιας ως πηγη αμινοξεων και ανευ πρωτεϊνικων συμπλοκων ζωϊκης προελευσης | |
| CY1113826T1 (el) | Ανοσοενισχυτικα για εμβολια | |
| DE60012711D1 (de) | Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe | |
| MXPA03011815A (es) | Vacuna de micoplasma bovis y metodos para reducir la neumonia en animales. | |
| WO2003003941A3 (en) | One dose vaccination with mycoplasma hyopneumoniae | |
| DE60036698D1 (de) | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen | |
| PT70610A (fr) | Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient | |
| ATE493495T1 (de) | Genmanipulierte dna-vakzine zur co-expression, methoden zu deren herstellung und deren verwendungen | |
| CY1108178T1 (el) | Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου | |
| ATE284613T1 (de) | Polynukleotid-impfstoff-formulierungen | |
| WO2002081621A3 (fr) | Vaccin contre le virus de la fievre du nil | |
| SE9903534D0 (sv) | Vaccin | |
| BR9814958A (pt) | Proteìna de cimento de tecido, composição farmacêutica, uso da proteìna de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido, molécula de ácido nucleico, vetor de expressão ou de clonagem, célula hospedeira, e, animal transgênico | |
| AR019785A1 (es) | Pestivirus no diseminantes | |
| TH55549B (th) | วัคซีนดีเอนเอที่ได้ปรับปรุงสำหรับสัตว์ในฟาร์ม | |
| NO20041564L (no) | Infeksios lakse anemi-virus vaksine | |
| BR0002602A (pt) | Vacina viva atenuada, uso de uma bactéria viva atenuada, e, processo para a preparação de uma vacina | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| ATE111356T1 (de) | Impfstoff gegen schweinedysenterie. | |
| BR0110791A (pt) | Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo | |
| ATE460945T1 (de) | Genetische adjuvanz-impfstoffe | |
| MX9604262A (es) | Antigenos de pasteurellaceae y vacunas relacionadas. |